A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Citadel Advisors LLC holds 3,800 shares of IRWD stock, worth $16,150. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,800
Previous 553,900 99.31%
Holding current value
$16,150
Previous $4.82 Million 99.5%
% of portfolio
0.0%
Previous 0.0%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$5.58 - $8.61 $2.36 Million - $3.65 Million
-423,741 Reduced 50.85%
409,533 $2.67 Million
Q1 2024

May 15, 2024

BUY
$8.32 - $15.45 $2.81 Million - $5.22 Million
337,803 Added 68.18%
833,274 $7.26 Million
Q4 2023

Feb 14, 2024

BUY
$8.79 - $11.51 $3.35 Million - $4.39 Million
381,454 Added 334.56%
495,471 $5.67 Million
Q3 2023

Nov 14, 2023

SELL
$8.25 - $11.35 $68,227 - $93,864
-8,270 Reduced 6.76%
114,017 $1.1 Million
Q2 2023

Aug 14, 2023

SELL
$10.1 - $11.6 $2.57 Million - $2.95 Million
-254,574 Reduced 67.55%
122,287 $1.3 Million
Q1 2023

May 15, 2023

BUY
$10.37 - $12.56 $3.17 Million - $3.84 Million
305,687 Added 429.49%
376,861 $3.96 Million
Q4 2022

Feb 14, 2023

BUY
$9.9 - $12.43 $521,284 - $654,501
52,655 Added 284.33%
71,174 $881,000
Q3 2022

Nov 14, 2022

BUY
$10.14 - $12.38 $187,782 - $229,265
18,519 New
18,519 $192,000
Q2 2022

Aug 15, 2022

SELL
$11.05 - $12.72 $9.24 Million - $10.6 Million
-836,648 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$10.61 - $12.88 $5.14 Million - $6.24 Million
484,521 Added 137.6%
836,648 $10.5 Million
Q4 2021

Feb 14, 2022

BUY
$10.86 - $13.95 $2.83 Million - $3.63 Million
260,393 Added 283.86%
352,127 $4.11 Million
Q3 2021

Nov 15, 2021

SELL
$11.92 - $13.92 $950,035 - $1.11 Million
-79,701 Reduced 46.49%
91,734 $1.2 Million
Q2 2021

Aug 16, 2021

SELL
$10.16 - $13.11 $1.16 Million - $1.5 Million
-114,339 Reduced 40.01%
171,435 $2.21 Million
Q1 2021

May 17, 2021

SELL
$9.04 - $11.86 $612,631 - $803,740
-67,769 Reduced 19.17%
285,774 $3.2 Million
Q4 2020

Feb 16, 2021

SELL
$9.05 - $12.2 $2.57 Million - $3.47 Million
-284,403 Reduced 44.58%
353,543 $4.03 Million
Q3 2020

Nov 16, 2020

SELL
$8.99 - $10.74 $429,730 - $513,382
-47,801 Reduced 6.97%
637,946 $5.74 Million
Q2 2020

Aug 14, 2020

SELL
$9.14 - $11.97 $483,323 - $632,973
-52,880 Reduced 7.16%
685,747 $7.08 Million
Q1 2020

May 15, 2020

SELL
$8.58 - $14.01 $4.92 Million - $8.04 Million
-573,538 Reduced 43.71%
738,627 $7.45 Million
Q4 2019

Feb 14, 2020

SELL
$8.22 - $14.0 $10.4 Million - $17.7 Million
-1,266,004 Reduced 49.1%
1,312,165 $17.5 Million
Q3 2019

Nov 14, 2019

SELL
$8.59 - $10.96 $13.5 Million - $17.2 Million
-1,573,393 Reduced 37.9%
2,578,169 $22.1 Million
Q2 2019

Aug 14, 2019

BUY
$9.8 - $12.89 $8.01 Million - $10.5 Million
817,824 Added 24.53%
4,151,562 $45.4 Million
Q1 2019

May 15, 2019

BUY
$8.27 - $12.73 $15.2 Million - $23.4 Million
1,835,553 Added 122.52%
3,333,738 $0
Q4 2018

Feb 14, 2019

BUY
$7.8 - $16.13 $8.15 Million - $16.9 Million
1,044,652 Added 230.34%
1,498,185 $13 Million
Q3 2018

Nov 13, 2018

SELL
$14.31 - $17.65 $783,973 - $966,955
-54,785 Reduced 10.78%
453,533 $0
Q2 2018

Aug 10, 2018

BUY
$11.83 - $16.2 $3.11 Million - $4.26 Million
263,123 Added 107.31%
508,318 $0
Q1 2018

May 11, 2018

BUY
$11.13 - $13.63 $2.73 Million - $3.34 Million
245,195 New
245,195 $3.78 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $651M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.